BSF Enterprise Plc (LON:BSFA)
London · Delayed Price · Currency is GBP · Price in GBX 1.250
-0.750 (-37.50%)
Jun 12, 2026, 4:23 PM GMT
BSF Enterprise Market Cap
BSF Enterprise has a market cap or net worth of 1.88 million as of June 12, 2026. Its market cap has decreased by -36.07% in one year.
Market Cap
1.88M
Enterprise Value
1.73M
Revenue
52.84K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.25
Market Cap Chart
Since July 26, 2019, BSF Enterprise's market cap has increased from 1.02M to 1.88M, an increase of 84.60%. That is a compound annual growth rate of 9.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 1.88M | -23.03% |
| Dec 31, 2025 | 2.44M | -16.73% |
| Dec 31, 2024 | 2.93M | -72.34% |
| Dec 29, 2023 | 10.59M | -26.28% |
| Dec 30, 2022 | 14.37M | 841.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cizzle Biotechnology Holdings | 12.54M |
| Genflow Biosciences | 12.18M |
| Oxford BioDynamics | 8.07M |
| OptiBiotix Health | 6.56M |
| CRISM Therapeutics | 5.97M |
| Theracryf | 5.26M |
| Nuformix | 4.83M |
| Thalia Therapeutics | 4.79M |